Cefixime Use in Children: When and Why

Cefixime Use in Children: When and Why

Saved in:

Bibliographic Details
Main Author:	Ben JK Tan
Format:	Article
Language:	English
Published:	Wiley 1995-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1995/170243
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determination of Cefixime Blood Plasma Levels by HPLC
by: V. V. Pisarev, et al.
Published: (2020-05-01)

Spectrophotometric determination of cefixime by charge transfer complex formation
by: Baghdad Science Journal
Published: (2013-09-01)

Comparison of cefixime and amoxicillin plus metronidazole in the treatment of chronic periodontitis
by: Dukić Smiljka, et al.
Published: (2016-01-01)

Spectrophotometer Determination of Cefixime in pure form and pharmaceutical preparation by Using Cloud point Extraction
by: Esraa Kadhim et al.
Published: (2020-06-01)

Formulation development, optimization, and evaluation of fast-dispersing tablets of cefixime trihydrate for pediatric use
by: Christine Philip, et al.
Published: (2025-05-01)

Impact of cefixime and probiotics on functional abdominal bloating: a pilot study
by: Rasha I Salama, et al.
Published: (2024-12-01)

Systematic Formulation Approach for Development and Evaluation of Cefixime G ranules for Pediatric Application
by: Nirmala Limarkar, et al.
Published: (2022-06-01)

Cefixime (advanced oral third-generation cephalosporin) and its place in clinical practice
by: Avdeev S.N., et al.
Published: (2025-03-01)

Spectrophotometric Determination of Cefixime by Oxidative Coupling Reaction with 4-Aminophenol in the Presence of Potassium periodate
by: Ali Ibraheem Khaleel, et al.
Published: (2023-01-01)

Reviewing: Why, when, what and how?
by: J. Karger-Kocsis
Published: (2014-07-01)

Data citation: what, when, why?
by: Thomas Lemberger
Published: (2018-12-01)

Characterization and evaluation of immobilized bimetallic and trimetallic nanoparticles fabricated using grape leaf extract and glass waste for cefixime removal
by: Teeba Salih Merjan, et al.
Published: (2025-07-01)

Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis.
by: Rui-xing Yu, et al.
Published: (2014-01-01)

A Validated RP-HPLC Method for Simultaneous Determination of Cefixime and Clavulanic Acid Powder in Pediatric Oral Suspension
by: Utsav Nepal, et al.
Published: (2022-01-01)

Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.
by: Lilith K Whittles, et al.
Published: (2017-10-01)

Restoration of Noncarious Cervical Lesions: When, Why, and How
by: Cesar dos Reis Perez, et al.
Published: (2012-01-01)

Why and when should be lipoprotein(a) level measured?
by: Miłosz Broncel, et al.
Published: (2023-12-01)

Blood pressure measurement: Why, how, when, and where?
by: E. O'Brien
Published: (2012-04-01)

Measuring Child Labor: The Who’s, the Where’s, the When’s, and the Why’s
by: Guilherme Lichand, et al.
Published: (2025-01-01)

Measuring Child Labor: The Who's, the Where's, the When's, and the Why's.
by: Guilherme Lichand, et al.
Published: (2025-01-01)

Lumbar Facet Joint Disease: What, Why, and When?
by: Wout Van Oosterwyck, et al.
Published: (2024-11-01)

Psychometric hepatic encephalopathy score (PHES) – when, how, why, and why not: a guide for the unfamiliar
by: Nikola Mumdzhiev, et al.
Published: (2024-12-01)

A comparative analysis of the efficacy of moxifloxacin and cefixime in the reduction of postoperative inflammatory sequelae after mandibular third molar surgery
by: Stošić Branimir, et al.
Published: (2022-01-01)

Why and when to prefer botulinum toxin injection in childhood strabismus?
by: Kadriye Erkan-Turan, et al.
Published: (2017-12-01)

Bronchoscopy in intensive care: to whom, when, why? (literature review)
by: O.Yu. Usenko, et al.
Published: (2025-05-01)

The 'new' paternalism in consumer credit regulation: When, why, and how?
by: Odorović Ana
Published: (2018-01-01)

Engineering of bacteria towards programmed autolysis: why, how, and when?
by: Changying Dong, et al.
Published: (2024-10-01)

Why, When and How Should Clinicians Use Physiology in Patients with Acute Coronary Syndromes?
by: Roberto Scarsini, et al.
Published: (2020-05-01)

When children can explain why they believe a claim, they suggest a better empirical test for that claim
by: Tone K. Hermansen, et al.
Published: (2024-12-01)

Optimisation of the removal of antibiotics from aqueous environments through ultrasonic processing with α-hematite nanoparticles using response surface methodology (case study: cefixime)
by: Ahmad Rajabizadeh, et al.
Published: (2025-05-01)

Anti-allergic ophthalmic drugs in general practice: Which, why and when?
by: N. Mohamed, et al.
Published: (2013-08-01)

«CLASS OF EVIDENCE IIB» FOR ACUTE HEART FAILURE: WHEN, WHO, WHY?
by: A. M. Namitokov, et al.
Published: (2019-02-01)

Synthesis and characterization of some biological active transition metal complexes of Schiff base derived from cefixime with mixed ligand 8-hydroxy quinoline
by: Baghdad Science Journal
Published: (2015-12-01)

High performance polyethersulfone/TiO2-AgBr-Ag photocatalytic membrane for Cefixime removal from water under visible light
by: Shahnaz Nayeri, et al.
Published: (2024-01-01)

Photocatalytic Degradation of Paracetamol and Cefixime Trihydrate Drugs using Fe2O3-ZnO and Fe2O3-ZnO/Ag Nanocomposites
by: Mansoor Farbod, et al.
Published: (2025-04-01)

Evaluating Streamflow Forecasts in Hydro‐Dominated Power Systems—When and Why They Matter
by: Rachel Koh, et al.
Published: (2024-03-01)

Soft tissue management as part of peri‑implantitis treatment: When, why and how?
by: Paternò Holtzman Lucrezia, et al.
Published: (2024-12-01)

When and why does observability increase honesty? The role of gossip and reputational concern
by: Annika S. Nieper, et al.
Published: (2025-01-01)

PSMA PET/CT in the low- to intermediate-risk prostate cancer: when and why?
by: Luca Sofia, et al.
Published: (2024-10-01)

Why and when you should avoid using z-scores in graphs displaying profile or group differences
by: Julia Moeller
Published: (2025-06-01)